长非编码RNA COX10-AS1 通过竞争性结合miR-1-3p来调节ORC6表达促进结质瘤的进展
Ge Zhang1, Xiang Tao1, Bao-Wei Ji1
1Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Neuroscience
|January 20, 2024
概括
长非编码RNA COX10-AS1通过通过海绵化miR-1-3p调节ORC6来促进质瘤的进展. 这种新的机制突出显示了COX10-AS1作为质母细胞瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是一种具有挑战性的主要中枢神经系统瘤.
- 长非编码RNAs (lncRNAs) 与瘤发展有关.
- 在质瘤中 lncRNA COX10-AS1 的作用尚不清楚.
研究的目的:
- 研究 lncRNA COX10-AS1 在质瘤进展中的作用和分子机制.
- 为了阐明涉及COX10-AS1,miR-1-3p和ORC6在质母细胞瘤中的调节轴.
主要方法:
- 对质瘤组织和细胞系中COX10-AS1表达的分析.
- 功能性试验:CCK-8,殖民地形成,Transwell试验.
- 在体内瘤生成测定和救援实验.
主要成果:
- 质瘤中COX10-AS1表达升高,与预后不佳相关.
- 抑制COX10-AS1抑制了质母细胞瘤细胞的增殖,迁移和入侵.
- COX10-AS1通过海绵化miR-1-3p作为ceRNA来提高ORC6的调节,促进质瘤细胞活力和瘤发生.
结论:
- 在lncRNA COX10-AS1/miR-1-3p/ORC6轴促进质瘤的进展.
- COX10-AS1是一种潜在的生物标志物和质瘤的治疗点.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


